A Case of Upper Tract Urothelial Carcinoma With Neuroendocrine Differentiation Successfully Treated With Enfortumab Vedotin and Pembrolizumab

ABSTRACT Introduction Upper tract urothelial carcinoma with neuroendocrine differentiation (UC‐NE) is extremely rare and generally associated with aggressive behavior and poor prognosis. Optimal treatment strategies remain unclear, particularly regarding the role of nectin‐4–targeted therapy. Case P...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Kosei Taniguchi, Mamoru Hashimoto, Takahito Nakayama, Saizo Fujimoto, Shingo Toyoda, Takashi Kikuchi, Marco Antonio De Velasco, Osamu Maenishi, Takafumi Minami, Kazutoshi Fujita
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2026-03-01
סדרה:	IJU Case Reports
נושאים:	Enfortumab vedotin Nectin‐4 neuroendocrine differentiation pembrolizumab upper tract urothelial carcinoma
גישה מקוונת:	https://doi.org/10.1002/iju5.70149
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!